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REVIEWARTICLE
MRAVersus DSA for Follow-Up of Coiled Intracranial
Aneurysms: AMeta-Analysis
M.J. van Amerongen, H.D. Boogaarts, J. de Vries, A.L.M. Verbeek, F.J.A. Meijer, M. Prokop, and R.H.M.A. Bartels
ABSTRACT
SUMMARY: MR angiography is proposed as a safer and less expensive alternative to the reference standard, DSA, in the follow-up of
intracranial aneurysms treated with endovascular coil occlusion. We performed a systematic review and meta-analysis to evaluate the
accuracy of TOF-MRA and contrast-enhancedMRA in detecting residual ﬂow in the follow-up of coiled intracranial aneurysms. Literature
was reviewed through the PubMed, Cochrane, and EMBASE data bases. In comparison with DSA, the sensitivity of TOF-MRAwas 86% (95%
CI: 82–89%), with a speciﬁcity of 84% (95%CI: 81–88%), for the detection of any recurrent ﬂow. For contrast-enhancedMRA, the sensitivity
and speciﬁcity were 86% (95%CI: 82–89%) and 89% (95%CI: 85–92%), respectively. Both TOF-MRA and contrast-enhancedMRA are shown
to be highly accurate for detection of any recanalization in intracranial aneurysms treated with endovascular coil occlusion.
ABBREVIATIONS: CE contrast-enhanced; GRADE grades of recommendation, assessment, development, and evaluation; SROC summary receiver operating
characteristic
The prevalence of unruptured intracranial aneurysms in theworld population is approximately 2–3%.1,2 The current
standard treatment to eliminate the risk of (re)bleeding is exclu-
sion of the aneurysm from the intracranial circulation by use of
endovascular detachable coil occlusion.3 However, recurrences
occur in approximately 20% of treated patients, leading to a need
for retreatment in approximately 9% of all cases.4
DSA is the reference standard for evaluating aneurysms after
coiling. However, this technique exposes patients to risks such as
cerebral thromboembolism, contrast nephrotoxicity, and ioniz-
ing radiation. The transient neurologic complication rate after
DSAhas been reported to be in the range of 0.34–1.3%,with a risk
for permanent neurologic complications of 0.5%. This risk accu-
mulates because repeated follow-ups are necessary.5-7
MRA can be used for follow-up of coiled intracranial aneu-
rysms, with TOF and contrast-enhanced (CE) MRA being the
most commonly used techniques currently available. MRA elim-
inates the risks of cerebral thromboembolism and ionizing radi-
ation. There is, however, a continuing debate aboutwhich of these
2 MRA techniques is best suited for aneurysm follow-up. The
systematic review and meta-analysis performed by Kwee and
Kwee8 in 2007 compared TOF-MRA and CE-MRA with DSA for
follow-up of coiled aneurysms. The analysis revealed a moderate
to high diagnostic performance of bothMRA techniques. Because
of the moderate methodologic quality of the studies available at
the time, Kwee and Kwee8 could not conclude whether MRA can
replace DSA as the standard method of reference. Since then, the
number of studies on this subject has more than doubled, and
study setup and statistical methodology have substantially
improved.
The goal of the current study is to systematically review the
medical literature to establish whether TOF-MRA and CE-MRA
can now be considered good enough for follow-up of patients
with coiled intracranial aneurysms.
MATERIALS AND METHODS
Data Sources
The medical literature comparing MRA and DSA for evaluating
intracranial aneurysms after coiling was reviewed through the use
of a variety of data bases—PubMed, EMBASE, and the Cochrane
Library—and was updated until March 2012 (On-line Table 1).
Study Selection
After an initial search of the literature by an experienced librarian,
duplicate publications were removed. From the pooled list of
publications, 2 researchers (M.J.v.A. and H.D.B.) independently
reviewed the titles and abstracts of the articles. Studies were ex-
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cluded if they did not compare MRA with DSA for follow-up of
patients with intracranial aneurysms treated with endovascular
coil occlusion. Conference abstracts, reviews, editorials, meta-
analyses, and animal studies were also excluded. Only articles in
English were screened. From the remaining articles, full-text ver-
sions were obtained and were independently evaluated by the
same researchers (M.J.v.A. and H.D.B.). Studies were eligible for
inclusion if they 1) evaluated MRA and DSA for follow-up of
patients with intracranial aneurysms treated with endovascular
coil occlusion; 2) contained data for 2 2 contingency tables; 3)
used the Raymond et al classification or other compatible scales to
grade recurrent flow in intracranial aneurysms9-11; 4) analyzed
TOF and CEMRA separately; and 5) provided data that excluded
stent-assistedcoilingof intracranial aneurysms. If the samedatawere
used in more than 1 article, the most recent version was included. If
the2researchersdisagreedabout selectionofarticles, an independent
third reviewer (R.H.M.A.B.) decided the outcome.
Study Quality
The Grades of Recommendation, Assessment, Development,
and Evaluation (GRADE) method was used to assess the meth-
odologic quality of the studies included in this review.12-22
The studies were independently assessed by the 2 researchers
(M.J.v.A. and H.D.B.) for limitations, indirectness, inconsis-
tency, imprecision, and publication bias. Agreement between
the researchers was quantified by use of Cohen .23 In the case
of disagreement, a third reviewer (R.H.M.A.B.) made the final
decision.
Data Analysis
The Meta-DiSc software (http://www.
hrc.es/investigacion/metadisc_en.htm) and
SPSS statistical package (version 19.0.0;
IBM, Armonk, New York) were used for
statistical analysis.24 To evaluate effect
size, 2  2 contingency tables were con-
structed from the articles comparing
MRA and DSA. If the true-positive rate,
false-positive rate, true-negative rate, or
false-negative rate was zero, a standard
correction of 0.5 was added to all of the
cells of the contingency table. Pooled sen-
sitivity and specificity with 95% confi-
dence intervals were constructed. Data
about the accuracy of MRA for grading
recurrent flow, as defined by Raymond et
al,9-11 were extracted if available. Classifi-
cation scales that were compatible with
Raymond et al were also utilized,meaning
that the findings could be assigned to 1 of
the following categories: complete occlu-
sion; residual neck (1–3 mm); and resid-
ual aneurysm (3 mm). Results were de-
picted in a Forest plot and a summary
receiver operating characteristic (SROC)
curve. An SROC curve plots the positive
rate against the false-positive rate of a di-
agnostic test at the different possible cut-
points. Heterogeneity between the studies was examined by use of




Our search string found 424 studies in PubMed, 12 in Cochrane,
and 580 articles in EMBASE (On-line Table 1). A total of 681
studies remained after removal of duplicates. After screening titles
and abstracts, 51 articles were deemed fit for full-text evalua-
tion.25-75 No new articles were found by screening their refer-
ences. After evaluation of the full-text versions, 3 articles were
excluded because they were review papers.37,51,58 Another 5 stud-
ies were omitted because they did not provide enough data for the
2 2 contingency tables.31,45,46,50,53 Four further studieswere left
out because they did not compare MRA with DSA,34,65,72,73 and
another 4 were not studying intracranial aneurysms treated with
endovascular coil occlusion.47,49,57,67 Two articles were excluded
because information about TOF-MRAandCE-MRAcould not be
separated.25,71 One article was excluded because it used CE–TOF-
MRA.30 Another 3 articles were excluded because their data were
used in earlier studies.35,41,44Threestudies includedpatientswhohad
been treatedwitha secondaryNeuroformstent (StrykerNeurovascular,
Fremont, California) and were thus omitted (Fig 1).52,54,63 This left
26 studies that were eligible for inclusion (Fig 1) (On-line Table
2).26-29,32,33,36,38-40,42,43,48,55,56,59-62,64,66,68-70,74,75 Of these articles,
24 researched TOF-MRA26-29,32,33,36,38-40,42,43,48,55,60-62,64,66,68-70,74,75
and 14 researched CE-MRA.29,32,36,40,42,56,59,60,62,66,68,70,74,75
FIG 1. Search results.
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Twelve studies assessed both TOF-MRA and CE-MRA for the
detection of recanalization in coiled intracranial aneurysms in the
same subjects.29,32,36,40,42,60,62,66,68,70,74,75
Study Quality Assessment
We analyzed the methodologic quality of the 26 articles included
in our review according to the GRADE criteria (On-line Table
3).12-22 There was disagreement between the assessments by the 2
researchers with respect to 5 of 104 GRADE scores, resulting in a
Cohen  of 0.81. All of the articles comprised valid studies com-
paring MRA with the reference standard (DSA). Because of this
validity, all of the studies started with a maximal quality score of
4.12 None of the articles gave any indication that they contained
serious inconsistencies or were imprecise.12-22 Two studies were
rated down because of indirectness; they did not provide enough
information concerning their MRA techniques or only included
anterior communicating artery aneurysms.28,32 Quality was
rated down in 14 studies because of the following major limi-
tations: the studies did not include consecutive patients, the
studies were not prospective, or there was no blinding of the
researchers.26,29,33,36,38-40,43,55,59,60,62,68,70
Data Analysis
The pooled results for the sensitivity and specificity of TOF-MRA
and CE-MRA are presented in Table 1. The sensitivity and speci-
ficity for the detection of any recanalization, meaning residual
FIG 2. Pooled sensitivity/speciﬁcity in detecting any recurrent ﬂow. A, Sensitivity for TOF-MRA. B, Speciﬁcity for TOF-MRA. C, Sensitivity for
CE-MRA. D, Speciﬁcity for CE-MRA.
Table 1: Pooled sensitivity and speciﬁcity for MRA versus DSA
TOF-MRA CE-MRA
Sensitivity Speciﬁcity Positive LR Negative LR Sensitivity Speciﬁcity Positive LR Negative LR
Any recanalization 86% (83–89%) 86% (83–89%) 6.3 (4.1–9.8) 0.17 (0.11–0.25) 85% (81–89%) 88% (84–91%) 6.2 (3.6–10.6) 0.16 (0.08–0.33)
Residual neck 78% (71–84%) 93% (90–95%) 9.6 (4.5–20.6) 0.29 (0.19–0.46) 56% (41–70%) 91% (84–95%) 6.3 (1.8–22.5) 0.40 (0.15–1.08)
Residual aneurysm 83% (77–88%) 96% (94–97%) 21.4 (10.5–43.7) 0.21 (0.13–0.35) 77% (68–85%) 90% (86–94%) 7.5 (3.8–14.7) 0.29 (0.18–0.48)
Note:—Percentages are shown with 95% conﬁdence intervals in parentheses; LR indicates likelihood ratio.
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neck or residual aneurysm, are shown in Fig 2A–D. TOF-MRA
had both a pooled sensitivity and specificity of 86% (95% CI:
83–89%). Pooled sensitivity and specificity of CE-MRAwere 85%
(95% CI: 81–89%) and 88% (95% CI: 84–91%), respectively.
SROC curves are displayed in Fig 3A,-B for TOF-MRA and CE-
MRA. As shown in Fig 2A–D, the results were subject to hetero-
geneity, with I2 values ranging between 66–80%. For subanalysis,
different study variables were distinguished: retrospective versus
prospective studies, 2D versus 3D DSA, different MR field
strengths, GRADE criteria, and weighted results according to
GRADE (Table 2).
DISCUSSION
The results of our meta-analysis reveal that MRA now has a high
degree of sensitivity and specificity in detecting any recanalization
during the follow-up of coiled intracranial aneurysms. However,
a subanalysis for residual neck or residual aneurysm (Raymond
scale 2 or 3, respectively) revealed lower sensitivity and specificity
of both MRA techniques compared with DSA as the reference
standard (Table 1). A possible explanation is the small number of
studies and patients included therein, which is reflected in the
large 95% confidence intervals. Another potential explanation is
false-positive findings seen on DSA possibly caused by pulsation
artifacts.48 However, this comparison makes MRA the reference
standard compared withDSA. Because our study comparedMRA
with the reference standard, DSA, these cases also were judged in
favor of DSA. This results in false-negative values for the MRA
and a lower sensitivity.
This subanalysis also showed lower sensitivities of the CE-
MRA compared with the TOF-MRA for the detection of resid-
ual neck or residual aneurysm. The contrast timing together
with the narrow interval of scanning in CE-MRA might be the
cause of this lower sensitivity. The short time window between
the arterial and venous phase of contrast enhancement to avoid
venous enhancement and vessel overlap lowers the spatial res-
olution.60 Additionally, the acquisition time for TOF-MRA is
much longer compared with CE images, leading to improved
resolution. The disadvantage of TOF-MRA is its limited cov-
erage; however, TOF is adequate for the evaluation of intracra-
nial vessels. Suboptimal imaging in CE-MRA may therefore
lead to more false-negative values, especially in small rem-
nants, lowering the sensitivity.
Significant sources of heterogeneity in this meta-analysis are
variations in study design and reporting of data. Evaluation of the
studies revealed 5 possible explanations for this heterogeneity: 1)
Publication bias remains a potential cause of heterogeneity, be-
cause articles with better results are more likely to be published
than studies with insignificant or negative findings. 2) Not all of
the studies had a prospective design and enrolled patients consec-
FIG 3. A, Summary receiver operating characteristic for TOF-MRA. B, Summary receiver operating characteristic for CE-MRA.
Table 2: Subclasses of sensitivity and speciﬁcity in TOF-MRA and CE-MRA
TOF-MRA CE-MRA
Sensitivity (95% CI) Speciﬁcity (95% CI) Sensitivity (95% CI) Speciﬁcity (95% CI)
Retrospective 90% (85–94%) 87% (82–91%) 93% (85–97%) 95% (90–98%)
Prospective 85% (81–88%) 86% (82–89%) 82% (77–87%) 82% (75–87%)
2D DSA 85% (82–89%) 91% (88–93%) 80% (74–85%) 82% (76–88%)
3D DSA 90% (84–95%) 76% (70–82%) 92% (86–96%) 93% (88–96%)
1–1.5T 86% (83–89%) 85% (81–88%) 89% (84–92%) 87% (83–91%)
3T 88% (82–92%) 87% (80–92%) 79% (71–86%) 83% (74–91%)
GRADE 2–3 87% (82–90%) 86% (81–89%) 77% (70–84%) 85% (79–90%)
GRADE 4 86% (81–90%) 87% (83–90%) 92% (86–95%) 90% (85–94%)
Weighted results 86% (85–88%) 86% (85–88%) 87% (85–89%) 88% (86–90%)
Percentages are shown with 95% conﬁdence intervals in parentheses.
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utively, which can be a cause of bias.76 Sixteen of the 26 were
prospective27,28,32,36,38,42,55,60-62,64,68-70,74,75; only 12 studies in-
cluded consecutive patients.28,32,42,48,56,60,61,64,66,69,74,75 Retro-
spective studies tended to be better, with low heterogeneity, com-
pared with the results of the prospective studies, though these
findings were not statistically significant (Table 2). 3) For the
reference standard, 8 reference studies used 3D (rotational) DSA
for comparison to MRA,38,39,56,59,66,69,70,74 whereas the other
studies used 2D DSA. Because 3D DSA is better at evaluating
recurrent flow in intracranial aneurysms,77,78 the use of the 2D
DSA may reduce calculated specificity but also increase calcu-
lated sensitivity of MRA if a true recanalization is missed by
DSA. The use of DSA as the reference standard will potentially
cause DSA false-negative values to count as MRA false-positive
values. In general, MRA tends to perform better when compared
with 3D DSA than when compared with 2D DSA (Table 2). 4)
Heterogeneity may also be caused by different field strengths
used in the various studies.79,80 Five studies only researched
3T MRA,42,61,64,68,74 whereas 2 articles studied both 3T and 1.5T
MRA techniques.60,70 Two studies were performed with a 1T
scanner.27,33 The rest of the articles evaluatedMRA by use of 1.5T
units. There is a trend toward higher pooled sensitivity and spec-
ificity of TOF-MRA with 3T units compared with 1.5T scanners,
though the 95% confidence intervals overlap (Table 2). This trend
might be caused by the higher resolution of images created with a
3T MR imaging compared with 1.5T scanners.81 However, the
sensitivity and specificity of 3T CE-MRA is lower than that at
1.5T, though this difference is not statistically significant. Again,
the small number of studies researching CE-MRA at 3T limits the
interpretation of results and might be the cause of this nonsignif-
icant difference without reflecting any underlying inferior-
ity.42,60,68,70,74 5) A final cause of heterogeneity might be the dif-
ference in study quality as judged by the GRADE criteria.12-22
GRADE 4 quality studies tend to have higher sensitivity and spec-
ificity. This difference reaches significance in sensitivity for CE-
MRA (Table 2). Weighted by GRADE, overall comparisons be-
tween TOF-MRA and CE-MRA revealed results that were similar
to the overall pooled results.
Our results provide a more detailed and updated evaluation
of the accuracy of MRA for follow-up of coiled intracranial
aneurysms than earlier work by Kwee and Kwee8 Our detailed
subanalysis of results reveals consistently good performance of
MRA techniques with pooled sensitivities and specificities well
above 80%. For the important question of residual aneurysms
(Raymond grade 4), CE-MRA even provides a pooled sensitiv-
ity and specificity90%, with a lower 95% confidence interval
of 85%.
CONCLUSIONS
This meta-analysis has revealed that MRA has a high diagnostic
performance when it comes to the detection of residual flow in
the follow-up of intracranial aneurysms treated with endovascu-
lar coil occlusion and therefore should be routinely used for
follow-up. CE-MRA did not perform significantly better than
TOF-MRA, indicating that follow-up with the latter should be
adequate.
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